instruction
stringlengths 51
2.18k
| output
stringlengths 1
833
| input
stringclasses 1
value |
|---|---|---|
I give you a description of a molecule, and you need to return one molecule in SMILES that meets the description. The description: It impacts alzheimer's treatment. The molecule is a bace inhibitor and belongs to the neurological treatment class of molecules.
|
COCC1(F)CC1
| |
Give me a molecule that satisfies the conditions outlined in the description: The molecule is a bace inhibitor that impacts both alzheimer's treatment and neurological treatment.
|
COCC1(F)CC1
| |
Conceptualize a molecule that meets the specified attribute(s): The molecule is a bace inhibitor and neurological treatment, and it impacts alzheimer's treatment.
|
COCC1(F)CC1
| |
Can you create a molecule that matches the given characteristics? The molecule is a bace inhibitor and belongs to the neurological treatment class of molecules, with the characteristic of being alzheimer's treatment.
|
COCC1(F)CC1
| |
The molecule is a bace inhibitor and belongs to the alzheimer's treatment class of molecules, with the characteristic of being neurological treatment. Use the above information to create a molecule.
|
COCC1(F)CC1
| |
The molecule is a inflammatory, a energy source, and a energy storage. The molecule is a fat storage that impacts obesity, pancreatitis, and metabolic syndrome. The molecule is a membrane stabilizer and nutrient, belonging to the thyroxine treatment class of molecules, and impacts atherosclerosis, cardiovascular disease, and cancer. Use the above information to create a molecule.
|
CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCC(C)C
| |
Could you please return a molecule that adheres to this description? The molecule is a fat storage that impacts pancreatitis, cancer, and thyroxine treatment. The molecule is a inflammatory and a energy source, impacting both atherosclerosis and metabolic syndrome. The molecule is a membrane stabilizer, energy storage, nutrient that impacts obesity and cardiovascular disease.
|
CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCC(C)C
| |
Give me a molecule that satisfies the conditions outlined in the description: The molecule is a inflammatory and a membrane stabilizer, impacting both metabolic syndrome and cardiovascular disease. The molecule is a energy source, a thyroxine treatment, and a fat storage, and it impacts obesity. The molecule is a nutrient and a energy storage that impacts atherosclerosis, cancer, and pancreatitis.
|
CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCC(C)C
| |
I give you a description of a molecule, and you need to return one molecule in SMILES that meets the description. The description: The molecule is a inflammatory, membrane stabilizer, fat storage, nutrient, energy source that impacts metabolic syndrome. It has an effect on cancer, impacting both atherosclerosis and cardiovascular disease. The molecule is a energy storage and belongs to the thyroxine treatment class of molecules, impacting both pancreatitis and obesity.
|
CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCC(C)C
| |
Build a molecule that meets the requirement: The molecule is a inflammatory, fat storage, energy storage that has an effect on cancer and impacts obesity. The molecule is a energy source and a membrane stabilizer that impacts cardiovascular disease, pancreatitis, and atherosclerosis. The molecule is a nutrient and thyroxine treatment, and it impacts metabolic syndrome.
|
CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCC(C)C
| |
Based on the given information, generate a molecule that meets the desired specifications: The molecule is a energy storage, thyroxine treatment, membrane stabilizer that impacts atherosclerosis, obesity, and cardiovascular disease. The molecule is a energy source, fat storage, inflammatory, nutrient that impacts pancreatitis and metabolic syndrome. It has an effect on cancer.
|
CCC(C)CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)CC
| |
I need a molecule that meets the following conditions: The molecule is a energy source, energy storage, thyroxine treatment that impacts pancreatitis, metabolic syndrome, and cardiovascular disease. The molecule is a inflammatory, fat storage, membrane stabilizer that impacts obesity, cancer, and atherosclerosis. The molecule is a nutrient. Please represent the molecule in SMILES.
|
CCC(C)CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)CC
| |
Give me a molecule that satisfies the conditions outlined in the description: The molecule is a energy source, a nutrient, and a fat storage, and it impacts metabolic syndrome. The molecule is a membrane stabilizer that affects cancer by impacting both atherosclerosis and cardiovascular disease. The molecule is a energy storage and a inflammatory that impacts obesity, pancreatitis, and thyroxine treatment.
|
CCC(C)CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)CC
| |
Could you please return a molecule that adheres to this description? The molecule is a membrane stabilizer, energy storage, energy source that belongs to the thyroxine treatment class of molecules and impacts atherosclerosis. The molecule is a inflammatory that impacts cardiovascular disease, pancreatitis, and obesity. The molecule is a fat storage and a nutrient, with effects on cancer and impacts on metabolic syndrome.
|
CCC(C)CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)CC
| |
Conceptualize a molecule that meets the specified attribute(s): The molecule is a energy storage that impacts atherosclerosis. The molecule is a inflammatory, fat storage, energy source that impacts metabolic syndrome and obesity. The molecule is a nutrient and a membrane stabilizer, which impacts pancreatitis, cancer, and cardiovascular disease, and is characterized as thyroxine treatment.
|
CCC(C)CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)CC
| |
Come up with a molecule based on the description: It impacts parkinson's disease, colorectal cancer, breast cancer, and alzheimer's disease. It has an effect on stomach cancer, and impacts diabetes mellitus, cardiovascular disease, and seizure.
|
CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CC=CC(O)CC=CCCCCC
| |
It has an effect on breast cancer, and impacts diabetes mellitus, parkinson's disease, and cardiovascular disease. It has an effect on colorectal cancer, and impacts alzheimer's disease, stomach cancer, and seizure. Use the above information to create a molecule.
|
CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CC=CC(O)CC=CCCCCC
| |
Come up with a molecule based on the description: It has an effect on both breast cancer and colorectal cancer, and impacts seizure. It impacts stomach cancer, cardiovascular disease, alzheimer's disease, diabetes mellitus, and parkinson's disease.
|
CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CC=CC(O)CC=CCCCCC
| |
Give me a molecule that satisfies the conditions outlined in the description: It has an effect on breast cancer, and impacts stomach cancer, cardiovascular disease, parkinson's disease, and diabetes mellitus. It has an effect on colorectal cancer, impacting both seizure and alzheimer's disease.
|
CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CC=CC(O)CC=CCCCCC
| |
Generate a molecule that fulfills the requirement: It has an effect on stomach cancer, impacting both seizure and diabetes mellitus. It has an effect on colorectal cancer, and impacts breast cancer, cardiovascular disease, parkinson's disease, and alzheimer's disease.
|
CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CC=CC(O)CC=CCCCCC
| |
Based on the given information, generate a molecule that meets the desired specifications: The molecule is a emulsifier, a surfactant, and a membrane stabilizer. The molecule is a nutrient, a energy storage, and a energy source.
|
C=C1CC23CC1(O)C(O)CC2C12CCCC(C)(C(=O)O1)C2C3C(=O)O
| |
Generate a molecule that fulfills the requirement: The molecule is a emulsifier, membrane stabilizer, nutrient, energy storage, surfactant. The molecule is a energy source.
|
C=C1CC23CC1(O)C(O)CC2C12CCCC(C)(C(=O)O1)C2C3C(=O)O
| |
Could you please return a molecule that adheres to this description? The molecule is a nutrient, energy source, membrane stabilizer, surfactant, emulsifier, energy storage.
|
C=C1CC23CC1(O)C(O)CC2C12CCCC(C)(C(=O)O1)C2C3C(=O)O
| |
Conceptualize a molecule that meets the specified attribute(s): The molecule is a membrane stabilizer, emulsifier, energy source, energy storage, nutrient, surfactant.
|
C=C1CC23CC1(O)C(O)CC2C12CCCC(C)(C(=O)O1)C2C3C(=O)O
| |
Based on the given information, generate a molecule that meets the desired specifications: The molecule is a energy source, nutrient, membrane stabilizer, emulsifier, energy storage, surfactant.
|
C=C1CC23CC1(O)C(O)CC2C12CCCC(C)(C(=O)O1)C2C3C(=O)O
| |
Can you create a molecule that matches the given characteristics? The molecule is a cholesterol translocation that impacts both non-alcoholic fatty liver disease and aging. The molecule is a stabilizing cytochrome oxidase and stabilizing mitochondrial structure, and it impacts barth syndrome. The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both tangier disease and diabetic heart disease.
|
CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C
| |
Generate a molecule based on this description: The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts tangier disease, barth syndrome, and aging. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts non-alcoholic fatty liver disease and diabetic heart disease.
|
CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C
| |
I need a molecule that meets the following conditions: The molecule is a stabilizing cytochrome oxidase, apoptosis, cholesterol translocation, proton trap for oxidative phosphorylation that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure that impacts aging, tangier disease, and diabetic heart disease. Please represent the molecule in SMILES.
|
CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C
| |
The molecule is a cholesterol translocation that impacts tangier disease, aging, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, apoptosis that impacts diabetic heart disease and non-alcoholic fatty liver disease. Use the above information to create a molecule.
|
CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C
| |
Conceptualize a molecule that meets the specified attribute(s): The molecule is a stabilizing cytochrome oxidase that impacts tangier disease. The molecule is a cholesterol translocation, apoptosis, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure. It impacts aging, diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease.
|
CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C
| |
Could you please return a molecule that adheres to this description? The molecule is a proton trap for oxidative phosphorylation that impacts aging. The molecule is a stabilizing cytochrome oxidase, a cholesterol translocation, and a stabilizing mitochondrial structure, and it impacts diabetic heart disease. The molecule is a apoptosis that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease.
|
CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C
| |
Could you please return a molecule that adheres to this description? The molecule is a cholesterol translocation that impacts both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a apoptosis, a stabilizing mitochondrial structure, and a proton trap for oxidative phosphorylation. The molecule is a stabilizing cytochrome oxidase that impacts tangier disease, barth syndrome, and aging.
|
CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C
| |
Build a molecule that meets the requirement: It impacts aging, diabetic heart disease, and tangier disease. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis. The molecule is a stabilizing mitochondrial structure that impacts both non-alcoholic fatty liver disease and barth syndrome.
|
CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C
| |
Build a molecule that meets the requirement: The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. The molecule is a apoptosis and a cholesterol translocation, impacting both aging and diabetic heart disease.
|
CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C
| |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts tangier disease, diabetic heart disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a apoptosis, a proton trap for oxidative phosphorylation, and a stabilizing cytochrome oxidase, and it impacts aging. Use the above information to create a molecule.
|
CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C
| |
Give me a molecule that satisfies the conditions outlined in the description: The molecule is a proton trap for oxidative phosphorylation and stabilizing cytochrome oxidase, and it impacts aging. The molecule is a apoptosis that impacts both non-alcoholic fatty liver disease and tangier disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure, impacting both barth syndrome and diabetic heart disease.
|
CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C
| |
Conceptualize a molecule that meets the specified attribute(s): The molecule is a cholesterol translocation that impacts both barth syndrome and tangier disease. The molecule is a stabilizing mitochondrial structure and apoptosis, and it impacts diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation, impacting both aging and non-alcoholic fatty liver disease.
|
CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C
| |
Can you create a molecule that matches the given characteristics? The molecule is a proton trap for oxidative phosphorylation, a stabilizing cytochrome oxidase, and a cholesterol translocation. The molecule is a stabilizing mitochondrial structure that impacts aging, barth syndrome, and diabetic heart disease. The molecule is a apoptosis that impacts both non-alcoholic fatty liver disease and tangier disease.
|
CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C
| |
Give me a molecule that satisfies the conditions outlined in the description: The molecule is a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, aging, and tangier disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both diabetic heart disease and barth syndrome. The molecule is both a cholesterol translocation and a stabilizing mitochondrial structure.
|
CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C
| |
I need a molecule that meets the following conditions: The molecule is a stabilizing mitochondrial structure that impacts both aging and tangier disease. The molecule is a apoptosis and a cholesterol translocation, impacting both diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation and stabilizing cytochrome oxidase, and it impacts barth syndrome. Please represent the molecule in SMILES.
|
CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C
| |
Come up with a molecule based on the description: The molecule is a nutrient that impacts both cardiovascular disease and pancreatitis. The molecule is a thyroxine treatment and a fat storage, impacting both atherosclerosis and metabolic syndrome.
|
CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC
| |
Can you create a molecule that matches the given characteristics? The molecule is a fat storage, nutrient, thyroxine treatment that impacts pancreatitis and atherosclerosis. It impacts both metabolic syndrome and cardiovascular disease.
|
CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC
| |
I give you a description of a molecule, and you need to return one molecule in SMILES that meets the description. The description: The molecule is a fat storage that impacts cardiovascular disease, metabolic syndrome, and pancreatitis. The molecule is a nutrient and belongs to the thyroxine treatment class of molecules, impacting atherosclerosis.
|
CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC
| |
Give me a molecule that satisfies the conditions outlined in the description: The molecule is a nutrient and fat storage, and it impacts atherosclerosis. It impacts cardiovascular disease, thyroxine treatment, pancreatitis, and metabolic syndrome.
|
CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC
| |
Could you please return a molecule that adheres to this description? The molecule is a fat storage and nutrient, belonging to the thyroxine treatment class of molecules, and impacts pancreatitis, cardiovascular disease, and atherosclerosis. It impacts metabolic syndrome.
|
CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC
| |
Come up with a molecule based on the description: The molecule is a stabilizing cytochrome oxidase, apoptosis, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and tangier disease. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts barth syndrome, aging, and diabetic heart disease.
|
CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCC
| |
Conceptualize a molecule that meets the specified attribute(s): The molecule is a cholesterol translocation and a apoptosis that impacts tangier disease, aging, and barth syndrome. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts diabetic heart disease and non-alcoholic fatty liver disease.
|
CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCC
| |
Can you create a molecule that matches the given characteristics? The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation, impacting both aging and non-alcoholic fatty liver disease. The molecule is a apoptosis that impacts tangier disease, barth syndrome, and diabetic heart disease. The molecule is both a stabilizing cytochrome oxidase and a cholesterol translocation.
|
CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCC
| |
Based on the given information, generate a molecule that meets the desired specifications: The molecule is a apoptosis that impacts both aging and diabetic heart disease. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase, impacting both non-alcoholic fatty liver disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and stabilizing mitochondrial structure, and it impacts tangier disease.
|
CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCC
| |
I give you a description of a molecule, and you need to return one molecule in SMILES that meets the description. The description: The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase that impacts barth syndrome, diabetic heart disease, and tangier disease. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis that impacts non-alcoholic fatty liver disease and aging.
|
CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCC
| |
Build a molecule that meets the requirement: The molecule is a membrane stabilizer and a energy source, it impacts atherosclerosis, and is thyroxine treatment. The molecule is a inflammatory and a fat storage, impacting both pancreatitis and metabolic syndrome. The molecule is a energy storage and a nutrient that impacts obesity, cardiovascular disease, and cancer.
|
CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCC(C)C
| |
Generate a molecule that fulfills the requirement: The molecule is a membrane stabilizer, fat storage, and energy storage that has an effect on cancer and impacts both atherosclerosis and obesity. The molecule is a energy source and nutrient, and it impacts cardiovascular disease. The molecule is a inflammatory and a thyroxine treatment, impacting both metabolic syndrome and pancreatitis.
|
CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCC(C)C
| |
I need a molecule that meets the following conditions: The molecule is a fat storage and energy source, and it impacts atherosclerosis. The molecule is a nutrient, thyroxine treatment, membrane stabilizer that impacts obesity and pancreatitis. The molecule is a inflammatory and a energy storage that impacts metabolic syndrome, cancer, and cardiovascular disease. Please represent the molecule in SMILES.
|
CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCC(C)C
| |
Based on the given information, generate a molecule that meets the desired specifications: It impacts both metabolic syndrome and pancreatitis. The molecule is a energy storage and a nutrient, which has an effect on cancer and impacts both cardiovascular disease and atherosclerosis. The molecule is a inflammatory, fat storage, energy source, thyroxine treatment, membrane stabilizer that impacts obesity.
|
CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCC(C)C
| |
Generate a molecule that fulfills the requirement: It impacts metabolic syndrome. The molecule is a fat storage, nutrient, energy source that impacts atherosclerosis, pancreatitis, and obesity. The molecule is a membrane stabilizer, energy storage, inflammatory, belonging to the thyroxine treatment class of molecules, and it has an effect on cancer as well as impacts cardiovascular disease.
|
CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCC(C)C
| |
Build a molecule that meets the requirement: It belongs to the liquid crystal class of molecules.
|
CC1(C)OCC(CCCO)CO1
| |
The molecule is a liquid crystal. Use the above information to create a molecule.
|
CC1(C)OCC(CCCO)CO1
| |
Come up with a molecule based on the description: It belongs to the liquid crystal class of molecules.
|
CC1(C)OCC(CCCO)CO1
| |
Conceptualize a molecule that meets the specified attribute(s): The molecule is a liquid crystal.
|
CC1(C)OCC(CCCO)CO1
| |
Suppose there is a molecule that meets the following description: It belongs to the liquid crystal class of molecules. Please write the SMILES representation of it.
|
CC1(C)OCC(CCCO)CO1
| |
Could you please return a molecule that adheres to this description? The molecule is a stabilizing mitochondrial structure, a cholesterol translocation, and a stabilizing cytochrome oxidase, and it impacts diabetic heart disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, barth syndrome, and aging. It impacts tangier disease.
|
CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C
| |
Suppose there is a molecule that meets the following description: The molecule is a apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts aging and tangier disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts barth syndrome, diabetic heart disease, and non-alcoholic fatty liver disease. Please write the SMILES representation of it.
|
CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C
| |
Could you please return a molecule that adheres to this description? The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation, impacting both tangier disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, apoptosis that impacts non-alcoholic fatty liver disease and aging. It impacts barth syndrome.
|
CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C
| |
Generate a molecule based on this description: The molecule is a apoptosis that impacts aging. The molecule is a stabilizing cytochrome oxidase, a cholesterol translocation, and a stabilizing mitochondrial structure, and it impacts diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and barth syndrome.
|
CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C
| |
Conceptualize a molecule that meets the specified attribute(s): The molecule is a cholesterol translocation that impacts non-alcoholic fatty liver disease, diabetic heart disease, and tangier disease. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts aging and barth syndrome.
|
CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C
| |
Build a molecule that meets the requirement: The molecule is a food additive, a emulsifier, and a nutritional supplement. The molecule is a stabilizing mitochondrial structure, a apoptosis, and a energy storage, and it impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, a cholesterol translocation, and a membrane stabilizer, and it impacts barth syndrome. The molecule is a energy source and a surfactant, it impacts aging, and is smooth. The molecule is a stabilizing cytochrome oxidase that impacts both tangier disease and diabetic heart disease.
|
CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC
| |
Come up with a molecule based on the description: The molecule is a apoptosis and a emulsifier, impacting both barth syndrome and tangier disease. The molecule is a energy source, a stabilizing mitochondrial structure, and a cholesterol translocation. The molecule is a food additive, stabilizing cytochrome oxidase, energy storage, membrane stabilizer. The molecule is a proton trap for oxidative phosphorylation and smooth, and it impacts diabetic heart disease. The molecule is a nutritional supplement and a surfactant, impacting both aging and non-alcoholic fatty liver disease.
|
CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC
| |
Generate a molecule based on this description: The molecule is a membrane stabilizer, a stabilizing cytochrome oxidase, and a energy source that impacts both barth syndrome and aging, and is smooth. The molecule is a surfactant, food additive, apoptosis, nutritional supplement that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a energy storage, stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation, emulsifier that impacts tangier disease.
|
CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC
| |
I give you a description of a molecule, and you need to return one molecule in SMILES that meets the description. The description: The molecule is a surfactant, a emulsifier, and smooth. The molecule is a apoptosis and nutritional supplement, and it impacts barth syndrome. The molecule is a stabilizing cytochrome oxidase that impacts aging, diabetic heart disease, and tangier disease. The molecule is a cholesterol translocation, stabilizing mitochondrial structure, membrane stabilizer, food additive. The molecule is a energy storage, a energy source, and a proton trap for oxidative phosphorylation, and it impacts non-alcoholic fatty liver disease.
|
CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC
| |
Can you create a molecule that matches the given characteristics? The molecule is a surfactant and a food additive, it impacts non-alcoholic fatty liver disease, and is smooth. The molecule is a stabilizing mitochondrial structure, nutritional supplement, proton trap for oxidative phosphorylation, energy source that impacts aging. The molecule is a energy storage, a stabilizing cytochrome oxidase, and a cholesterol translocation, and it impacts diabetic heart disease. The molecule is a emulsifier, membrane stabilizer, apoptosis that impacts tangier disease and barth syndrome.
|
CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC
| |
Come up with a molecule based on the description: The molecule is a proton trap for oxidative phosphorylation that impacts both tangier disease and diabetic heart disease. The molecule is a cholesterol translocation that impacts both non-alcoholic fatty liver disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase, a stabilizing mitochondrial structure, and a apoptosis, and it impacts aging.
|
CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCC
| |
Suppose there is a molecule that meets the following description: The molecule is a stabilizing mitochondrial structure and a apoptosis, impacting both diabetic heart disease and tangier disease. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts aging, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase. Please write the SMILES representation of it.
|
CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCC
| |
Build a molecule that meets the requirement: The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts diabetic heart disease, non-alcoholic fatty liver disease, and aging. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts tangier disease and barth syndrome.
|
CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCC
| |
Give me a molecule that satisfies the conditions outlined in the description: The molecule is a cholesterol translocation that impacts both diabetic heart disease and aging. The molecule is a stabilizing mitochondrial structure and a apoptosis, impacting both tangier disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and stabilizing cytochrome oxidase, and it impacts non-alcoholic fatty liver disease.
|
CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCC
| |
Build a molecule that meets the requirement: The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts aging, tangier disease, and diabetic heart disease. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, apoptosis that impacts non-alcoholic fatty liver disease and barth syndrome.
|
CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCC
| |
Build a molecule that meets the requirement: The molecule is a apoptosis that impacts both barth syndrome and aging. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation, impacting both diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and cholesterol translocation, and it impacts tangier disease.
|
CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C
| |
Suppose there is a molecule that meets the following description: The molecule is a cholesterol translocation and a apoptosis, impacting both aging and tangier disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a stabilizing mitochondrial structure that impacts barth syndrome. Please write the SMILES representation of it.
|
CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C
| |
Conceptualize a molecule that meets the specified attribute(s): The molecule is a apoptosis and a stabilizing mitochondrial structure, impacting both aging and diabetic heart disease. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase, impacting both non-alcoholic fatty liver disease and tangier disease. The molecule is a proton trap for oxidative phosphorylation that impacts barth syndrome.
|
CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C
| |
Can you create a molecule that matches the given characteristics? It impacts tangier disease, non-alcoholic fatty liver disease, diabetic heart disease, barth syndrome, and aging. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis, cholesterol translocation.
|
CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C
| |
Suppose there is a molecule that meets the following description: The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure, impacting both aging and tangier disease. The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, apoptosis that impacts diabetic heart disease and barth syndrome. It impacts non-alcoholic fatty liver disease. Please write the SMILES representation of it.
|
CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C
| |
I need a molecule that meets the following conditions: The molecule is a orexin type 2 receptor agonist. Please represent the molecule in SMILES.
|
COC(=O)N1CCCC(NS(C)(=O)=O)C1Cc1cccc(-c2cccc(OC)c2)c1
| |
Generate a molecule that fulfills the requirement: The molecule is a orexin type 2 receptor agonist.
|
COC(=O)N1CCCC(NS(C)(=O)=O)C1Cc1cccc(-c2cccc(OC)c2)c1
| |
Give me a molecule that satisfies the conditions outlined in the description: It belongs to the orexin type 2 receptor agonist class of molecules.
|
COC(=O)N1CCCC(NS(C)(=O)=O)C1Cc1cccc(-c2cccc(OC)c2)c1
| |
Generate a molecule that fulfills the requirement: It belongs to the orexin type 2 receptor agonist class of molecules.
|
COC(=O)N1CCCC(NS(C)(=O)=O)C1Cc1cccc(-c2cccc(OC)c2)c1
| |
Give me a molecule that satisfies the conditions outlined in the description: It belongs to the orexin type 2 receptor agonist class of molecules.
|
COC(=O)N1CCCC(NS(C)(=O)=O)C1Cc1cccc(-c2cccc(OC)c2)c1
| |
The molecule is a fat storage that belongs to the thyroxine treatment class of molecules, impacting metabolic syndrome, pancreatitis, and cardiovascular disease. The molecule is a nutrient that impacts atherosclerosis. Use the above information to create a molecule.
|
CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC
| |
Suppose there is a molecule that meets the following description: The molecule is a nutrient that impacts both atherosclerosis and metabolic syndrome. The molecule is a thyroxine treatment and a fat storage, impacting both cardiovascular disease and pancreatitis. Please write the SMILES representation of it.
|
CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC
| |
Suppose there is a molecule that meets the following description: The molecule is a fat storage and nutrient, belonging to the thyroxine treatment class of molecules, and impacts pancreatitis, cardiovascular disease, and atherosclerosis. It impacts metabolic syndrome. Please write the SMILES representation of it.
|
CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC
| |
The molecule is a thyroxine treatment that impacts metabolic syndrome. The molecule is a fat storage and a nutrient that impacts cardiovascular disease, pancreatitis, and atherosclerosis. Use the above information to create a molecule.
|
CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC
| |
I need a molecule that meets the following conditions: The molecule is a nutrient that impacts metabolic syndrome, atherosclerosis, and pancreatitis. The molecule is a fat storage and thyroxine treatment, and it impacts cardiovascular disease. Please represent the molecule in SMILES.
|
CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC
| |
Based on the given information, generate a molecule that meets the desired specifications: It impacts barth syndrome, aging, non-alcoholic fatty liver disease, and tangier disease. The molecule is a stabilizing mitochondrial structure, apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase. The molecule is a cholesterol translocation that impacts diabetic heart disease.
|
CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC
| |
Generate a molecule based on this description: The molecule is a stabilizing cytochrome oxidase, a cholesterol translocation, and a proton trap for oxidative phosphorylation, and it impacts diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, tangier disease, and aging.
|
CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC
| |
I need a molecule that meets the following conditions: The molecule is a cholesterol translocation that impacts tangier disease, aging, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts barth syndrome. Please represent the molecule in SMILES.
|
CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC
| |
Could you please return a molecule that adheres to this description? The molecule is a stabilizing mitochondrial structure, apoptosis, stabilizing cytochrome oxidase that impacts diabetic heart disease and barth syndrome. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts tangier disease, aging, and non-alcoholic fatty liver disease.
|
CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC
| |
Could you please return a molecule that adheres to this description? The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts aging, tangier disease, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, apoptosis, cholesterol translocation that impacts diabetic heart disease and non-alcoholic fatty liver disease.
|
CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC
| |
Based on the given information, generate a molecule that meets the desired specifications: The molecule is a surfactant, food additive, cholesterol translocation, stabilizing mitochondrial structure. The molecule is a energy source and smooth, impacting aging, barth syndrome, and diabetic heart disease. The molecule is a nutritional supplement, a membrane stabilizer, and a stabilizing cytochrome oxidase, and it impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, emulsifier, energy storage, apoptosis that impacts tangier disease.
|
CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C
| |
Generate a molecule based on this description: The molecule is a nutritional supplement, a proton trap for oxidative phosphorylation, and a surfactant, and it impacts aging. The molecule is a emulsifier and a energy storage, it impacts barth syndrome, and is smooth. The molecule is a cholesterol translocation, membrane stabilizer, energy source, stabilizing mitochondrial structure. The molecule is a apoptosis and a food additive, impacting both tangier disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase that impacts diabetic heart disease.
|
CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C
| |
Generate a molecule that fulfills the requirement: The molecule is a emulsifier. The molecule is a apoptosis, a surfactant, and a nutritional supplement, and it impacts non-alcoholic fatty liver disease. The molecule is a energy source that impacts tangier disease, aging, and barth syndrome. The molecule is a food additive, a stabilizing mitochondrial structure, and a membrane stabilizer, and it impacts diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation, energy storage, and smooth.
|
CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C
| |
Build a molecule that meets the requirement: The molecule is a proton trap for oxidative phosphorylation, nutritional supplement, emulsifier, apoptosis, and smooth. The molecule is a stabilizing cytochrome oxidase, energy storage, cholesterol translocation, food additive that impacts tangier disease. The molecule is a membrane stabilizer and a stabilizing mitochondrial structure, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a energy source and a surfactant, impacting both barth syndrome and aging.
|
CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C
| |
Build a molecule that meets the requirement: The molecule is a apoptosis and energy storage, and it impacts non-alcoholic fatty liver disease. The molecule is a surfactant, a emulsifier, and a cholesterol translocation, and it impacts barth syndrome. The molecule is a nutritional supplement that impacts both aging and tangier disease. The molecule is a proton trap for oxidative phosphorylation and a food additive, it impacts diabetic heart disease, and is smooth. The molecule is a stabilizing mitochondrial structure, energy source, membrane stabilizer, stabilizing cytochrome oxidase.
|
CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.